Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

With more than four decades of experience in delivering data and technology solutions to financial entities and professionals across the globe, Bloomberg is known for setting a high standard of ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Welltower ( (WELL)) ...

Keepit, the only vendor-independent cloud dedicated to SaaS data protection, today announced that it has been selected as winner of the “Business Continuity Cyber Solution of the Year” award in the ...

COPENHAGEN, Denmark–(BUSINESS WIRE)–Keepit, the only vendor-independent cloud dedicated to SaaS data protection, today announced that it has been selected as winner of the “Business Continuity Cyber ...

Programs such as Meds to Bed can work in tandem with retail pharmacies to offer accessible medications for patients. What are the benefits to the patient and other stakeholders when you invest in a ...

In early 2025, an electrical transformer exploded in Albany, N.Y., knocking out fiber-optic cable to a local elementary school. The school was without internet connectivity for three days, a major ...